» Articles » PMID: 12373550

Molecular Imaging of Perfusion Disturbances in Glaucoma

Overview
Journal Amino Acids
Specialty Biochemistry
Date 2002 Oct 10
PMID 12373550
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Ocular ischemia resulting from perfusion disturbances may play a major role in initiation of glaucoma. Possibly secondary to ischemia autoimmunogenic events are activated in glaucoma patients with increased prevalence of systemic autoimmune diseases. The determination of potential molecular markers in blood leukocytes could be useful for early noninvasive diagnostics of glaucoma. Our study using subtractive hybridization showed altered gene expression in leukocytes of glaucoma patients in comparison to age and sex matched healthy subjects. Subtracted genes encoding lymphocyte IgE receptor (Fc epsilon RII/CD23), T cell-specific tyrosine kinase, thromboxan A2 receptor, alkaline phosphatase and Na(+)/K(+)-ATPase are differentially expressed in circulating leukocytes of glaucoma patients. These genes show expression profiles characteristic for adherent leukocytes which could be an important contributor to blood-brain barrier breakdown which has been found in glaucoma patients.

Citing Articles

Analysis of Glaucoma Associated Genes in Response to Inflammation, an Examination of a Public Data Set Derived from Peripheral Blood from Patients with Hepatitis C.

Player J, Riordan S, Duncan R, Koulen P Clin Ophthalmol. 2022; 16:2093-2103.

PMID: 35770250 PMC: 9236525. DOI: 10.2147/OPTH.S364739.


The discovery of the Flammer syndrome: a historical and personal perspective.

Flammer J, Konieczka K EPMA J. 2017; 8(2):75-97.

PMID: 28725290 PMC: 5486542. DOI: 10.1007/s13167-017-0090-x.


Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy.

Nath M, Halder N, Velpandian T Indian J Ophthalmol. 2017; 65(3):191-197.

PMID: 28440247 PMC: 5426123. DOI: 10.4103/ijo.IJO_866_16.


Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs.

Yeghiazaryan K, Flammer J, Golubnitschaja O EPMA J. 2012; 1(2):263-72.

PMID: 23199064 PMC: 3405317. DOI: 10.1007/s13167-010-0032-3.


Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible?.

Golubnitschaja O, Yeghiazaryan K, Flammer J EPMA J. 2012; 1(2):237-44.

PMID: 23199062 PMC: 3405318. DOI: 10.1007/s13167-010-0031-4.